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Proneural basic helix– loop–helix (bHLH) transcription factors are critical positive regulators of neuronal differentiation in a variety of
species and are required for proper differentiation of various subtypes of neurons. Although bHLH factors demonstrate some unique
functions during neural development, they share the ability to regulate neuronal differentiation, potentially by targeting overlapping sets of
genes. To assess this, we performed a screen in ectoderm animal cap tissue to identify direct transcriptional targets shared by two Xenopus
ato-related bHLH factors, Xath5 and XNeuroD. Candidate target genes identified in this screen include several transcriptional regulators
(Xebf2, Xebf3, XETOR and NKL), an RNA binding protein (elrC), a cell cycle component (Xgadd45g) and several novel genes.
Overexpression of either Xath5 or XNeuroD induced ectopic in vivo expression of these candidate target genes. Conversely, blocking ato-
related bHLH activity prevented endogenous nervous system expression of these genes. Therefore, we have identified a set of genes that can
be regulated by multiple ato-related bHLH factors and may function as critical effectors of proneural bHLH-mediated differentiation.
D 2005 Elsevier Inc. All rights reserved.Keywords: Proneural; bHLH transcription factor; Neuronal differentiation; Target genesIntroduction
The mature nervous system contains a broad assortment
of neuronal subtypes. Although these cell types vary in
molecular signature, they share certain broad morpholog-
ical and molecular attributes. Formation of diverse neuro-
nal lineages throughout the nervous system utilizes a
number of signaling mechanisms and, ultimately, requires
proper coordinated regulation of gene expression. One
class of transcription factors critical to neuronal determi-
nation and differentiation across species is that of
proneural basic helix–loop–helix (bHLH) transcription
factors (Bertrand et al., 2002). In Drosophila, there are
two predominant proneural bHLH families, one related to
the achaete-scute (as-c) complex of genes and a second
related to atonal (ato) (Campuzano and Modolell, 1992;0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2005.06.033
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E-mail address: Monica.Vetter@neuro.utah.edu (M.L. Vetter).Jarman et al., 1993). A number of as-c and ato-related
bHLH genes exist in vertebrates, and they display varying
spatial and temporal expression patterns within the devel-
oping nervous system (Bertrand et al., 2002; Brunet and
Ghysen, 1999). These proneural transcription factors pro-
mote terminal differentiation of many neuronal subtypes,
but they can also function to specify different neuronal
lineages (Akagi et al., 2004; Bertrand et al., 2002; Lee and
Pfaff, 2003).
The ability of vertebrate proneural bHLH factors to
regulate neuronal differentiation has been noted in several
systems. For example, misexpression of XNeuroD in X.
laevis embryos promotes neurogenesis in non-neural
ectoderm (Lee et al., 1995), and many other bHLH factors
have comparable effects (Ferreiro et al., 1994; Kanekar et
al., 1997; Ma et al., 1996). Similarly, expression of bHLH
factors in cultured P19 cells promotes neuronal differ-
entiation (Farah et al., 2000). Proneural bHLH factors also
serve diverse roles in vivo and, in some cases, specify
particular neuronal subtypes. For example, along the85 (2005) 570 – 583
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lon, the proneural bHLH factors ngn2 and Mash1 are
expressed in complementary patterns and regulate the
formation of glutamatergic and GABA neurons, respec-
tively (Fode et al., 2000; Parras et al., 2002). In other
cases, bHLH factors must cooperate with other regional
and temporal factors to contribute to neuronal subtype
identity. For example, cooperative activity between pro-
neural bHLHs and homeodomain transcription factors in
retinal subtype specification has been demonstrated (Hata-
keyama et al., 2001; Inoue et al., 2002; Lee and Pfaff,
2003). Nevertheless, proneural bHLH factors share a
common ability to promote neuronal differentiation, raising
the question of how this is regulated.
One way that proneural bHLH factors may promote
differentiation in a variety of neuronal subtypes is through
the expression of both distinct and common downstream
genes. In isolated ectoderm tissue, the X. laevis bHLH
factors Xash1 and X-Ngnr-1 can upregulate certain genes
selectively or activate a common gene in different temporal
manners, but both bHLH factors similarly activate expres-
sion of the general neuronal differentiation marker N-
tubulin (Talikka et al., 2002). This result supports the idea
that the shared function of bHLH factors may be mediated
in part through shared transcriptional targets. There are
several candidate classes of bHLH target genes, including
genes encoding other neural-specific transcription factors
and regulators of cell cycle exit. For example, Drosophila
ato transactivates the gene senseless, a zinc-finger tran-
scription factor that, in turn, functions to maintain high
levels of proneural bHLH expression (Nolo et al., 2000). In
X. laevis, XNeuroD can transactivate the gene for the EBF/
Olf family transcription factor Xebf3 (Pozzoli et al., 2001).
Although neuronal differentiation is associated with cell
cycle exit, the relationship between these events appears
complex. Some cell cycle regulators are thought to function
upstream of proneural bHLHs during neurogenesis, while
others are thought to function downstream (de la Calle-
Mustienes et al., 2002; Vernon et al., 2003). Resolving the
relationships between proneural bHLH factors and cell cycle
regulators should help clarify how neuronal differentiation
and mitotic exit are coupled.
Although some target genes for proneural bHLH factors
have been described, a systematic approach to identify
genes directly targeted by multiple proneural bHLH factors
has not been done until this point. We have defined a set of
gene targets for two ato-related bHLH factors Xath5 and
XNeuroD that includes transcriptional and translational
regulators, a putative neuronal structural protein and a cell
cycle regulator. We determined that these genes, which are
expressed in the developing nervous system, are direct
transcriptional targets for activated Xath5 and XNeuroD ex
vivo in animal cap ectoderm tissue. We can activate ectopic
expression of these genes in vivo by overexpressing either
Xath5 or XNeuroD, and we also show that endogenous
expression of these target genes is inhibited in vivo byexpression of a dominant-negative bHLH. Collectively, our
results suggest that ato-related bHLH factors can activate a
common set of direct gene targets with varied cellular
functions during neurogenesis. These effectors may be
important components of a neuronal differentiation program
activated by different bHLH factors in various neuronal
lineages.Methods
Animal cap experiments
Capped injection messenger RNA (mRNA) was gener-
ated in vitro using the Message Machine kit (Ambion) from
the following DNA templates: pCS2-hGR, pCS2MT-Xath5-
hGR and pCS2MT-XNeuroD-hGR (Hutcheson and Vetter,
2001). pCS2-hGR was made by PCR subcloning the
hormone binding domain of the human glucocorticoid
receptor (hGR) into pCS2+ (J. Rasmussen and M.L. Vetter).
One nanogram of hGR, Xath5-hGR or XNeuroD-hGR
mRNA was injected into pigmented embryos at the 1-cell
stage, embryos were grown until stage 8–9 and animal cap
ectoderm was isolated as previously described (Hutcheson
and Vetter, 2001). When indicated, animal cap explants were
incubated for 3 h in 1XMMR plus 30 AM dexamethasone
(DEX) hormone to activate hormone-inducible constructs.
All samples were treated for 3 h with 10 AM cycloheximide
(CHX), a treatment paradigm that has been shown to be
consistently adequate to prevent new protein synthesis, as
monitored by 35S-methionine incorporation (Hutcheson and
Vetter, 2001; Pozzoli et al., 2001). Total RNA was then
extracted using Trizol Reagent (Invitrogen). First strand
cDNA was generated by reverse transcribing with Super-
script II and oligodT12-18 primers (Invitrogen). DEX-
dependent activation of Xath5-hGR or XNeuroD-hGR was
confirmed by performing PCR for XBrn3d (accession
AF184979), Xebf3 (accession AF040994) and EF1a
(accession X52975) as previously described (Hutcheson
and Vetter, 2001; Pozzoli et al., 2001). We confirmed CHX
block of protein synthesis by performing PCR for the
indirect downstream target XNF-M (Pozzoli et al., 2001)
(accession BC074454) and verified that excised animal caps
were not contaminated with mesoderm by performing PCR
for Xbra (accession BC072031). Primer sequences are
available upon request.
Fluorescent Differential Display
A minimum of 20 Ag of total RNA from four inde-
pendent animal cap experiments was pooled for each
condition: hGR: +CHX, Xath5-hGR: DEX + CHX,
Xath5-hGR: +DEX + CHX and XNeuroD-hGR: +DEX +
CHX and sent to GenHunter (Nashville, TN) for Fluo-
rescent Differential Display (FDD) screening as previously
described (Liang et al., 1994). A total of 144 duplicate PCR
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arbitrary primers and either a G- or A-anchored oligodT
reverse primer. Gel images of PCR reactions were visually
examined for products showing differential expression in
both Xath5-hGR and XNeuroD-hGR DEX-treated samples.
Selected bands were gel excised, re-amplified with the
appropriate oligodT-anchored primer and H-AP primer and
then ligated into the PCR-TRAP vector (GenHunter). PCR-
TRAP FDD insert bands were sequenced with Lgh and Rgh
primers (GenHunter), and sequences were identified by
using BLAST to screen the GenBank nucleotide (nr) and
EST databases.
Real-time quantitative PCR
To confirm upregulation of candidate Xath5-hGR and
XNeuroD-hGR gene targets identified by FDD, real-time
quantitative RT-PCR (Q-PCR) was performed. To confirm
direct proneural bHLH activation of candidate target genes,
expression was compared in uninduced (DEX) and
induced (+DEX) Xath5-hGR and XNeuroD-hGR-express-
ing animal caps that were all treated with CHX. To control
for non-specific activation of genes, we compared target
gene expression in uninjected CHX-treated caps and hGR-
injected caps treated with both DEX and CHX. To
determine relative gene expression, the threshold cycle
(Ct) of each candidate was normalized to the Ct of PCR
product for the housekeeping gene EF1a and/or Histone4.
Ct is defined as the number of cycles required for a select
quantity of PCR product during the exponential phase of
PCR product generation. A difference in one Ct represents a
two-fold difference in initial cDNA template concentration.
Q-PCR was performed in 96-well format using SYBR
Green Master Mix (Applied Biosystems) on a 7900HT Real
Time PCR System (Applied Biosystems). MacVector soft-
ware program was used to design the gene-specific pri-
mers against selected FDD band sequences (Supplemental
Table 1).
RNA injections
Capped injection mRNAwas generated in vitro using the
Message mMachine kit (Ambion) and the following DNA
templates: pCS2MT-XNeuroD (Lee et al., 1995); pCS2MT-
Xath5a (Kanekar et al., 1997); pCS2MT-Xash3b (Turner
and Weintraub, 1994); pCS2-Xath3 (Perron et al., 1999b);
pCS2MT-X-Ngnr-1a (Ma et al., 1996); pCS2MT-
Xath5EnR+NLS; pCS2-nh-galactosidase; pCS2-GFP-LT.
RNA was injected into 1 blastomere of 2-cell stage albino
embryos at the following concentrations: Xath5a (500 pg or
750 pg), XNeuroD (500 pg), Xath5EnR (500 pg–1 ng), X-
Ngnr-1 (500 pg), Xath3 (500 pg), Xash3 (500 pg). Either
GFP (400 pg) or h-galactosidase (h-gal) (80 pg) mRNAwas
co-injected as a tracer. Embryos were grown to the desired
stage (Nieuwkoop and Faber, 1994) and fixed for 30–60
min in MEMFA at room temperature. X-gal staining wasperformed on h-gal-injected embryos as described (Turner
and Weintraub, 1994). Embryos co-injected with GFP
mRNA were pre-sorted for GFP expression restricted to
either the left or right side.
In situ hybridization
Whole mount in situ hybridization (wmish) was
performed on albino embryos using a previously described
protocol (Harland, 1991) using BM Purple (Boehringer
Mannheim) as a staining substrate for alkaline phosphatase
(Hutcheson and Vetter, 2001) to monitor altered gene
expression in microinjected embryos. At minimum, two
independent sets of experiments (microinjection followed
by wmish) were performed for each condition. In situ
hybridization on paraffin-embedded and sectioned X.
laevis embryos was performed as described (Hutcheson
and Vetter, 2001). Antisense DIG-labeled RNA probes
were generated using the following plasmid templates by
performing in vitro transcription reactions with digoxige-
ninin-11-UTP (Roche): pXelc-3 (elrC) (Good, 1995);
NIBB clone XL013f01 (SBT1); pCMV-SPORT6-NKL
(IMAGE clone 4058009) (Lennon et al., 1996); pBS-
Xebf2 (Pozzoli et al., 2001); pBS-Xebf3 (Pozzoli et al.,
2001); pBS-XETOR (Cao et al., 2002); pGEMT-Xgadd45g
(de la Calle-Mustienes et al., 2002); pBS-SVOP; pBS-
Xath5a (Kanekar et al., 1997); pBS-N-tubulin (Richter et
al., 1988); pBS-X-Delta-1 (Dorsky et al., 1997); pBS-
XNeuroD (Lee et al., 1995); pBS-XSox2 (M. Schneider
and M.L. Vetter).
Xath5EnR construct
The Xath5-Engrailed Repressor (Xath5EnR) was con-
structed by replacing the putative C-terminal activation
domain of Xath5 (Kanekar et al., 1997) with the repressor
domain of Engrailed (EnR) (Smith and Jaynes, 1996) using
overlap extension PCR (Horton et al., 1989). A nuclear
localization sequence (NLS) was added to the C-terminal end
of the EnR construct. The individual Xath5 and EnR frag-
ments were amplified separately in a primary PCR reaction
using the following primers: 5V EcoRI-Xath5 forward
primer—5VTCGGAATTCCATGAAGTCAGATTCACCQ
AG3V; 3VXath5 reverse primer—5VCAGGGCCATCQ
TCGAGTGGATCAGTCCTGCTGTACC3V; 5VEnR forward
primer—5VACTGATCCACTCGAGATGGCCCTGGAGGQ
ATCGC3V; 3V EnR+NLS-XbaI reverse primer—5VGCCTQ
TTTCTAGACTATACCTTACGCTTCTTCTTTGGAGC-
GGATCCCAGAGCAGATTTC3V. Following extension
PCR, the appropriate size band was gel purified, digested
with EcoRI and XbaI and ligated into pCS2+MT. The
resulting Myc-Xath5EnR+NLS chimeric construct was con-
firmed by sequencing and by in vitro transcription/translation
using the TNTR Coupled Reticulolysate System (Promega)
followed by Western analysis using the anti-myc antibody
9E10.
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Identification of shared gene targets for Xath5 and
XNeuroD in animal caps
To identify common direct transcriptional targets for
the ato-related bHLH transcription factors Xath5 and
XNeuroD, we used hormone-inducible fusion proteins
consisting of the hormone binding domain of the human
glucocorticoid receptor (hGR) fused to either Xath5 or
XNeuroD. These fusion proteins are inactive except in the
presence of glucocorticoid hormone or analogs, such as
dexamethasone (DEX). When expressed in X. laevis
embryos, these fusion transcription factors induce ectopic
neuronal differentiation following DEX treatment, thereby
reproducing the proneural function of Xath5 and XNeuroD
in a temporally controlled manner (Hutcheson and Vetter,
2001). We screened for target genes in isolated animal
cap ectoderm since this tissue is non-neural but can
undergo neuronal differentiation when proneural genes are
expressed (Hutcheson and Vetter, 2001; Lee et al., 1995).
We injected mRNA encoding Xath5-hGR or XNeuroD-
hGR into 1-cell stage X. laevis embryos, isolated ectoderm
animal cap tissue at stage 9 and then incubated the animal
caps for 3 h in either the absence or presence of DEX to
induce transcriptional activity of the fusion proteins. To
ensure that only direct gene targets of Xath5-hGR and
XNeuroD-hGR were being activated, we co-treated animal
caps with the protein synthesis inhibitor cycloheximide
(CHX), which consistently and effectively prevents protein
translation in this animal cap assay, as demonstrated by
blocked 35S-methionine incorporation (Hutcheson and
Vetter, 2001; Pozzoli et al., 2001). Animal caps were then
harvested, total RNA isolated and first strand cDNA
prepared. We confirmed successful activation of Xath5-
hGR and XNeuroD-hGR within our DEX-treated animal
cap samples since we could detect robust upregulation of
the known Xath5 and XNeuroD target genes, XBrn3d
(Hutcheson and Vetter, 2001) and Xebf3, respectively
(Pozzoli et al., 2001) (Figs. 1A, B). To control for non-
specific induction of XBrn3d and Xebf3, we also injected
embryos with mRNA encoding the hGR domain only and
treated animal caps isolated from these embryos with both
DEX and CHX and found no upregulation (Figs. 1A, B).
To confirm that our dissected animal caps did not contain
any contaminating mesoderm, which can induce neural
tissue, we performed RT-PCR and showed that the
mesoderm-specific gene X-brachyury (Xbra) was not
expressed (Fig. 1C). We also confirmed that our CHX
treatment was effective since we did not detect expression
of the terminal neuronal differentiation gene neurofila-
ment-M (XNF-M), which is known to be indirectly
activated by XNeuroD-hGR (Fig. 1C) (Pozzoli et al.,
2001).
To identify genes upregulated by Xath5-hGR and
XNeuroD-hGR, Fluorescent Differential Display (FDD)was performed using 144 unique primer sets (see Methods).
Gel images of duplicate PCR FDD samples were visually
scanned, and candidate shared gene targets for Xath5-hGR
and XNeuroD-hGR were identified using two main criteria:
the PCR band must be present in duplicate reactions of
DEX-activated Xath5-hGR and XNeuroD-hGR samples but
absent from both of our control conditions, non-induced
Xath5-hGR and DEX-treated hGR-injected samples (Fig.
1D). Based on these criteria, we selected sixteen bands to
subclone and sequence, and these sequences were then
screened by BLAST against the GenBank nucleotide and
EST databases.
Confirmation of shared Xath5 and XNeuroD gene targets in
animal caps
To confirm that our selected FDD clones corresponded
to Xath5-hGR and XNeuroD-hGR gene targets in animal
cap tissue, we designed sequence specific primers against
all 16 FDD clones and performed quantitative RT-PCR
(Q-PCR) (see Supplemental Table 1 for gene list and
primer sequences). We repeated the animal cap assay,
activating Xath5-hGR and XNeuroD-hGR with DEX in
the presence of CHX. Animal caps expressing Xath5-hGR
and XNeuroD-hGR treated with CHX alone served as
uninduced controls. To control for non-specific effects
mediated through the hGR domain and/or DEX treatment,
we also compared the relative expression of candidate
genes in hGR-expressing animal caps treated with DEX +
CHX to uninjected animal caps treated with CHX by Q-
PCR and found no significant differences (data not
shown). Q-PCR was performed on the cDNA generated
from these animal cap samples to determine which of the
16 candidate genes identified by FDD could be confirmed
as shared bHLH targets, as well as to assess the relative
robustness of target gene upregulation. For comparison,
we quantified induction of XBrn3d, a known direct gene
target for both Xath5 and XNeuroD (Hutcheson and
Vetter, 2001), and Xebf3, a previously identified XNeuroD
target (Pozzoli et al., 2001). Using this method, we
confirmed 9 of the 16 candidate genes as direct transcrip-
tional targets for both Xath5-hGR and XNeuroD-hGR in
animal caps, with varying levels of induction, as deter-
mined by relative expression in Xath5-hGR and XNeuroD-
hGR DEX-activated samples as compared to non-activated
samples (Table 1). In addition, although not identified in
the FDD screen, we found that Xebf3 is also a direct
target of Xath5-hGR in the animal cap assay (Table 1).
Thus, in total, we have identified 10 genes that are directly
targeted by both Xath5-hGR and XNeuroD-hGR in animal
caps.
Classes of Xath5-hGR and XNeuroD-hGR gene targets
Gene information regarding the confirmed FDD clone
sequences is summarized in Table 1. Five of the nine
Fig. 1. Identification of shared Xath5-hGR and XNeuroD-hGR gene targets by Fluorescent Differential Display. (A–C) RT-PCR for the indicated genes was
first performed to ensure transcriptional activation of the hGR fusion proteins with DEX treatment and to monitor quality of the isolated animal caps. Animal
caps were isolated from stage 8 embryos and cultured for 3 h in the presence (+) or absence () of hormone DEX and in the presence (+) of the protein
synthesis inhibitor CHX. EF1a was used for normalization. Water was used in place of cDNA in no-template control (NTC) samples, and cDNA from stage 18
to 25 whole embryos was used for positive controls (pos). (A) XBrn3d was upregulated in Xath5-hGR-injected animal caps treated with DEX even in the
presence of CHX, but not in uninduced caps or in caps injected with hGR domain. (B) Similarly, DEX treatment of XNeuroD-hGR-injected animal caps
resulted in Xebf3 upregulation even with CHX co-treatment, but Xebf3 was not detected in control samples. (C) XNF-M was not detectable in CHX-treated
caps, confirming inhibition of protein synthesis, and the mesoderm-specific gene Xbra was also undetectable. (D) Animal caps were injected and treated with
DEX and CHX as indicated in the table, and transcript profiles were compared by FDD. Example image depicts a portion of a larger FDD gel showing the PCR
products generated from duplicate reactions of a single primer set. Arrow indicates a band present in DEX-treated animal caps corresponding to a candidate
common target of Xath5-hGR and XNeuroD-hGR.
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genes: Xebf2, XETOR, NKL, elrC and Xgadd45g. We used
an additional confirmed clone sequence that did not match
any known gene or EST to screen a stage 28–30 X. laevis
head cDNA library and identified the X. laevis homolog of
synaptic vesicle SV2-related protein (SVOP) (to be reported
elsewhere). The remaining three confirmed FDD clones
were assigned a Shared BHLH Target (SBT) number. SBT1
matched an X. laevis EST sequence (92% identity)
representing an unknown gene. SBT2 and SBT3 did not
match any genes or ESTs in the GenBank databases or in the
X. tropicalis JGI Genome Assembly, were not identified
during screening of our stage 28–30 head cDNA library
and, therefore, were not considered for further study.
These target genes fall into several functional classes,
including transcription factors (Xebf3, Xebf2, XETOR,
NKL), an RNA-binding protein (elrC), a cell cycle regulator
(Xgadd45g) and a neuronal-specific protein that is synap-
tically enriched in rat brain (SVOP) (Cao et al., 2002; de la
Calle-Mustienes et al., 2002; Dubois et al., 1998; Good,
1995; Janz et al., 1998; Lamar et al., 2001; Pozzoli et al.,
2001).Shared target genes are upregulated by Xath5 and XNeuroD
in vivo
Xebf2, Xebf3, XETOR, NKL, elrC and Xgadd45g are all
known to be expressed within the developing X. laevis
nervous system (Cao et al., 2002; de la Calle-Mustienes et
al., 2002; Dubois et al., 1998; Lamar et al., 2001; Perron et
al., 1999a; Pozzoli et al., 2001), and we confirmed that
SVOP and SBT1 expression also were neural-restricted
(Figs. 2C, H and data not shown). Furthermore, over-
expression of proneural bHLH factors in developing neurula
stage X. laevis embryos has been shown to induce ectopic
expression of Xebf3, NKL, XETOR and Xgadd45g (Cao et
al., 2002; de la Calle-Mustienes et al., 2002; Lamar et al.,
2001; Pozzoli et al., 2001). Therefore, we hypothesized that
all of the shared target genes we identified (Table 1) should
be regulated in vivo by overexpression of either Xath5 or
XNeuroD, during neurogenesis. To assess this, we injected
capped mRNA encoding either full-length Xath5 or
XNeuroD into 1 cell of 2-cell stage embryos and then
performed in situ hybridization at neurula stages to visualize
expression of each target gene. Overexpression of Xath5
Table 1
Confirmed direct gene targets of Xath5-hGR and XNeuroD-hGR in animal
cap tissue
Gene
name
Gene function Xath5-hGR
induction
(fold
change)a
XNeuroD-hGR
induction
(fold
change)a
Accession
number
Xebf2 HLH transcription
factor
12 18 AF040994
XETOR Transcriptional
repressor
5 15 AF212198
NKL Zn finger
transcription factor
4 5 AF249341
elrC RNA binding protein 9 13 U17598
Xgadd45g Cell cycle regulator 2 5 AJ414384
SVOPb Related to synaptic
vesicle 2 family
2 3 N/A
SBT1 Unknown function 11 15 BJ044439
SBT2 Unknown function 2 4 N/A
SBT3 Unknown function 2 3 N/A
Xebf3 HLH transcription
factor
10 20 AF040994
XBrn3d POU transcription
factor
9 11 AF184979
a Gene upregulation in animal caps as determined by quantitative
RT-PCR.
b Xenopus SVOP homolog identified by cDNA library screening with
unknown FDD clone sequence.
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elrC (27/34 embryos, Fig. 2A), XETOR (21/21 embryos,
Fig. 2B), SBT1 (22/32 embryos, Fig. 2C), Xgadd45g (31/35
embryos, Fig. 2D), Xebf2 (21/23 embryos, Fig. 2E), Xebf3
(22/26 embryos, Fig. 2F), NKL (30/35 embryos, Fig. 2G)
and SVOP (29/36 embryos, Fig. 2H). Previously published
results have already demonstrated ectopic activation of
Xebf3, XETOR and Xgadd45g following XNeuroD over-
expression (Cao et al., 2002; de la Calle-Mustienes et al.,
2002; Lamar et al., 2001; Pozzoli et al., 2001), and we
determined that the remaining targets are also XNeuroD-
responsive in vivo. Following XNeuroD injection, we
observed ectopic expression of elrC (18/22 embryos, Fig.
2I) SBT1 (15/21 embryos, Fig. 2J), NKL (27/38 embryos,
Fig. 2K) and SVOP (17/21 embryos, Fig. 2L). Thus, in
addition to directly activating these genes in animal caps,
Xath5 and XNeuroD can positively regulate expression of
these genes in vivo, supporting the idea that they can
function as immediate effectors of proneural bHLH factors
during development.
Dominant-negative Xath5 blocks proneural function of
ato-related bHLH factors
We hypothesized that if the genes identified in our animal
cap assay are in vivo targets of proneural bHLHs then we
should be able to block expression of these genes in
differentiating neurons by disrupting endogenous proneural
bHLH function. To test this, we generated a dominant-
negative Xath5 construct (Xath5EnR) in which the tran-scriptional activation domain of Xath5 was replaced with
the repressor domain of the Drosophila Engrailed protein
(Smith and Jaynes, 1996). We expect that our Xath5EnR
construct will compete with endogenous proneural bHLHs
for promoter E-box binding sites, thereby repressing the
expression of proneural bHLH target genes. We first showed
that Xath5EnR could interfere with Xath5 function since
the ectopic N-tubulin expression induced by overexpression
of Xath5 alone (28/28 embryos, Fig. 3A; Kanekar et al.,
1997) was inhibited by coexpression of Xath5EnR (28/30
embryos, Fig. 3B). To determine the specificity of Xath5-
EnR, we tested whether coexpression of Xath5EnR blocked
the proneural function of additional bHLH factors. We
found that the ectopic N-tubulin expression caused by
overexpression of the ato-related bHLH factors XNeuroD
(21/21 embryos, Fig. 3C) or Xath3 (26/28 embryos, Fig. 3E)
was also blocked by coexpression of Xath5EnR (22/22
embryos for XNeuroD, Fig. 3D; 20/22 embryos for Xath3,
Fig. 3F). X-Ngnr-1 is another ato-related bHLH factor that
acts upstream of XNeuroD to regulate neurogenesis. We
found that the ability of overexpressed X-Ngnr-1 to promote
ectopic XNeuroD expression (32/38 embryos, Fig. 3G) was
blocked by Xath5EnR coexpression (28/34 embryos, Fig.
3H). Thus, all tested ato-related bHLH factors were
effectively inhibited by Xath5EnR. To determine if
Xath5EnR could also interfere with the function of as-c-
related bHLH factors, we injected Xash3 and then
performed in situ hybridization for the Notch receptor
ligand, X-Delta-1. We monitored the expression of X-Delta-
1 rather than N-tubulin since Chitnis and Kintner (1996)
showed that Xash3 can actually suppress N-tubulin expres-
sion in the neural plate due to strong activation of X-Delta-1
expression leading to lateral inhibition (Chitnis and Kintner,
1996). In fact, X-Delta-1 is likely a direct target for Xash3
and thus is a good reporter for whether Xash3 activity has
been suppressed or not (Chitnis and Kintner, 1996). We
found that the ability of Xash3 to upregulate X-Delta-1
expression (36/46 embryos, Fig. 3I) was not blocked by co-
injection of Xath5EnR (32/45 embryos with increased X-
Delta-1, Fig. 3J), while the ability of XNeuroD to induce
ectopic X-Delta-1 expression (25/27 embryos, Fig. 3K) was
efficiently suppressed by coexpression of Xath5EnR (28/35
embryos, Fig. 3L). Similarly, overexpression of Xath3
induced ectopic X-Delta-1 expression (13/22 embryos, data
not shown), and this was suppressed by coexpression of
Xath5EnR (30/31 embryos, data not shown). Thus,
Xath5EnR is a broad-spectrum inhibitor of ato-related
bHLH factors but not as-c-related factors, a useful feature
since we have screened for shared gene targets of ato family
factors. This further argues that the DNA-binding specificity
for ato- vs. as-c-related factors may be distinct, as has
recently been shown in Drosophila (Powell et al., 2004).
We also reasoned that overexpression of XathEnR alone
should block endogenous proneural bHLH function. We
found that injection of 1 ng of Xath5EnR into 1 cell of 2-cell
stage embryos completely blocked expression of N-tubulin
Fig. 2. Xath5 or XNeuroD overexpression induces ectopic expression of candidate target genes identified by FDD. Xath5 or XNeuroD mRNAwas injected into
1 cell of 2-cell stage embryos with GFP mRNA as an injection marker. Whole mount in situ hybridization was performed to visualize expression of candidate
target genes. Xath5 overexpression induces significant ectopic broad expression of elrC (A) and XETOR (B) on the injected side of the embryo. The novel gene
SBT1 is expressed in the developing nervous system (arrows in panels C and J) and displays a scattered pattern of ectopic expression on the Xath5-injected
side. Xath5 overexpression results in upregulation of Xgadd45g (D), Xebf2 (E) and Xebf3 (F) within the developing nervous system, with weaker ectopic
expression also induced in lateral ectodermal regions. At early tailbud stages, Xath5 induces ectopic expression of NKL (G) and SVOP (H) on the injected side
of the embryo. NeuroD overexpression also induces broad robust ectopic elrC expression (I) and scattered ectopic expression of SBT1 (J). At early tailbud
stages, NeuroD injection promotes scattered ectopic expression of NKL (K) and SVOP (L) on the injected side. Ectopic gene expression is indicated with
brackets. Embryos in panels (A–G) and (I–K) are presented as dorsal views with anterior to the top and injected side on the left. Tailbud stage embryos in
panels (H) and (L) are shown as lateral views with anterior to the right.
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addition, we confirmed that Xath5EnR did not non-
specifically interfere with early development, including
neural plate formation, as the expression of the neural plate
marker Sox2 (Mizuseki et al., 1998) was unaltered follow-
ing Xath5EnR injection (20/22 embryos, Fig. 3N).
Dominant-negative Xath5 blocks expression of shared
Xath5/XNeuroD target genes in vivo
To determine if ato family bHLH function is required for
normal expression of our candidate gene targets, we injected
Xath5EnR into 1 cell of 2-cell stage embryos and performed
in situ hybridization for each target gene of interest.
Overexpression of this dominant-negative construct inhi-
bited endogenous expression of elrC (32/40 embryos, Fig.
4A), SBT1 (23/33 embryos, Fig. 4B), Xebf2 (29/38
embryos, Fig. 4C), XETOR (15/23 embryos, Fig. 4D) and
Xebf3 (25/27 embryos, Fig. 4E) at early neurula stages.Inhibition of SVOP (24/30 embryos, Fig. 4F), Xgadd45g
(23/31 embryos, Fig. 4G) and NKL (20/29 embryos, Fig.
4H) expression was also apparent at later stages on the
Xath5EnR-injected side of the embryo. These results
suggest that ato-related bHLH function is required for
proper expression of these target genes in the developing X.
laevis nervous system.
Retinal expression of shared target genes
To more precisely correlate the expression of proneural
bHLH factors with the expression of candidate target genes,
we examined mRNA expression of these genes in the X.
laevis retina. Because most of our target gene expression
analysis thus far had been done at early neurula stages, a
time when XNeuroD is active, but before the onset of
endogenous Xath5 expression, we reasoned that analysis
within the retina of older embryos would allow us to
compare the spatial expression of Xath5 with some target
Fig. 3. Dominant-negative Xath5 inhibits proneural function of ato-related bHLH factors. mRNA for indicated transcription factor(s) was co-injected into 1 cell
of 2-cell stage embryos with mRNA encoding h-galactosidase (h-gal) or GFP. Arrowheads indicate endogenous expression of indicated genes visualized by
whole mount in situ hybridization. Xath5 (A), XNeuroD (C), Xath3 (E) and X-Ngnr-1 (G) induce ectopic neurogenesis, indicated by visualization of ectopic N-
tubulin (A, C, E) or XNeuroD (G) (ectopic expression indicated by brackets). The proneural activity of these bHLH factors is blocked by co-injection of
Xath5EnR (B, D, F, H). However, proneural activity of Xash3, indicated by increased X-Delta-1 expression on the injected side (I), is not inhibited by
Xath5EnR co-injection (J), while the ability of XNeuroD to induce expression of X-Delta-1 (K) is efficiently suppressed by coexpression of Xath5EnR (L).
Injection of Xath5EnR alone suppresses primary neurogenesis on the injected side (bracket in M) but does not disrupt expression of the neural plate marker
Sox2 (N). Panels (A–H) and (K–N) are dorsal views with anterior to the top. Panels (I) and (J) are anterior views with dorsal to the top. Injected side is on the
right in all images, and pink staining (B, F–L, N) and light blue staining (D) denote expression of h-gal injection tracer.
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expressed in the retina, including Xash1, Xash3 and X-
Ngnr-1, which precede Xath5, XNeuroD and Xath3 and
overlap with Xath5 expression (Perron et al., 1998). The
mature frog retina is an ideal structure for examining
sequential gene activation during neuronal differentiation
since the central retina contains post-mitotic differentiated
neuronal cells, but the peripheral ciliary marginal zone
(CMZ) contributes to the growth of the retina throughout
life and contains progenitors that are spatially distributed
based on their developmental state (Dorsky et al., 1995;
Perron et al., 1998; Wetts et al., 1989). Retinal stem cells
reside in the most peripheral region of the CMZ, while
progenitors beginning to undergo neuronal differentiation
reside in the most central CMZ region, closest to the layersof fully differentiated cells (see Fig. 5A). Xath5 expression
is excluded from peripheral CMZ stem cells but is observed
in proliferating progenitors and early post-mitotic cells
within the central CMZ (Kanekar et al., 1997). We predicted
that direct target genes of proneural bHLHs, including
Xath5, would be expressed within the central CMZ region
but excluded from the most peripheral domain. We found
that these target genes display two basic patterns of
expression. SBT1, Xgadd45g and XETOR are restricted
to progenitors and early differentiating cells of the CMZ in a
pattern highly overlapping with that of Xath5 and other
bHLH factors expressed in the retina, but excluded from
cells within the peripheral CMZ (Figs. 5C–E, brackets). We
see a second pattern for elrC and Xebf3, which are absent
from the peripheral CMZ (Figs. 5F and G), but turn on in
Fig. 4. Dominant-negative Xath5 inhibits expression of Xath5/XNeuroD
shared target genes. Injection of Xath5EnR inhibits endogenous expression
of elrC (A), SBT1 (B), Xebf2 (C), XETOR (D), Xebf3 (E), SVOP (F) and
Xgadd45g (G) in mid-neurula and tailbud stage embryos. Xath5EnR
injection also blocks endogenous expression of NKL (H) at tailbud stages.
Endogenous expression of target genes is indicated by arrowheads, and loss
of or reduced expression of genes on Xath5EnR injected side is indicated
by brackets. All embryos are shown as dorsal views with anterior to the top
and Xath5EnR-injected side on the left, except for the NKL probed embryo
(H), which is shown as a lateral view with anterior to the right. Pink
staining (A) and light blue staining (B) correspond to h-galactosidase
injection tracer. Embryos in remaining panels (C–H) were presorted for
GFP to identify injected side. Abbreviations: sc, spinal cord; e, eye.
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their final position in the mature retinal layers. These
genes then persist in a subset of post-mitotic cells in the
central retina. This pattern is virtually identical to that of
XBrn3d, a previously described target for Xath5 and
XNeuroD (Hutcheson and Vetter, 2001). The differences
between these two basic patterns could be due to activation
by early versus late bHLH genes (such as X-Ngnr-1 versus
Xath5), modulation by other factors or differences in the
timing of target gene activation. MyoD, for example, has
been shown to activate direct target genes with both early
and late temporal kinetics (Bergstrom et al., 2002).
Collectively, these neural plate and retinal expression
patterns support the conclusion that the candidate genes
identified as direct targets for ato-related bHLH factors in
animal caps are also directly transactivated by numerous
ato-related bHLH factors in differentiating neurons through-
out development.Discussion
Proneural bHLH transcription factors are a conserved
family of critical intrinsic mediators of differentiation across
neuronal subtypes. To distinguish specific downstream
molecules and pathways that account for this important
broad function of bHLH factors, we identified a set of genes
that are directly transactivated by two ato-related factors,
Xath5 and XNeuroD, in animal caps. We expect that these
genes may also be directly regulated by ato-related bHLH
factors during nervous system development for several
reasons. First, all of these candidate target genes are
expressed either predominantly or exclusively in the
developing nervous system, and almost all are detectable
in differentiating primary neurons of the neural plate
following XNeuroD expression (Figs. 2C, J, 4B) (Cao et
al., 2002; de la Calle-Mustienes et al., 2002; Dubois et al.,
1998; Lamar et al., 2001; Perron et al., 1999a; Pozzoli et al.,
2001). Moreover, retinal expression of these candidate
genes suggests that Xath5, or other ato-related bHLH
factors in the retina, may be responsible for upregulating
many of these targets during retinal neurogenesis. Second,
in vivo misexpression of Xath5 or XNeuroD, which
promotes the formation of ectopic neurons, can upregulate
all of these candidate genes. Third, in vivo expression of the
dominant-negative bHLH Xath5EnR, which blocks activity
of ato-related bHLH factors, inhibits endogenous expres-
sion of all candidate genes. Collectively, these results all
support the idea that ato family bHLH factors directly
transactivate this set of common candidate genes in vivo.
What remains to be demonstrated is that ato-related bHLH
factors directly interact with regulatory elements controlling
expression of these candidate target genes.
ato-related bHLH factors directly upregulate genes that fall
into diverse functional categories
Proneural bHLH factors promote neuronal differentiation
through several conserved mechanisms. Activation of these
factors is concomitant with upregulation of cell cycle
components and with cell cycle exit of neuronal progenitors
(Farah et al., 2000; Liu et al., 2004; Wallace et al., 2000).
Proneural bHLH factors directly target neuronal-specific
genes (Hutcheson and Vetter, 2001; Matter-Sadzinski et al.,
2001; Pozzoli et al., 2001) and actively repress acquisition
of some glial cell fates (Nieto et al., 2001; Sun et al., 2001;
Tomita et al., 2000). In addition, potentiation of lateral
inhibition signaling is mediated through bHLH activation of
the Notch receptor ligand Delta (Fode et al., 1998; Heitzler
et al., 1996; Ma et al., 1996). The genetic cascade activated
by Ngn2 in the developing mouse cortex includes an
assortment of transcription factors and components of cell
adhesion/axon pathfinding (Mattar et al., 2004). Therefore,
it is not surprising that we have identified common
candidate gene targets for Xath5 and XNeuroD with
functions distributed across several categories, including
Fig. 5. Proneural bHLH target genes are expressed in late progenitors or post-mitotic neurons of the X. laevis retina. (A) Schematic of stage 41/42 X. laevis
retinal cross-section. The central retina contains post-mitotic cells stratified into 3 major layers: retinal ganglion cell (RGC) layer, inner nuclear layer (INL) and
outer nuclear layer (ONL). The ciliary marginal zone (CMZ) contains retinal stem cells within the most peripheral region (per) and early differentiating
progenitors within the central region (cntl). The entire neural retina is surrounded by retinal pigment epithelium (RPE). (B–G) In situ hybridizations were
performed on paraffin sections of stage 41/42 X. laevis embryos. (B) Xath5 expression is restricted to the central CMZ (bracket) and excluded from the most
peripheral CMZ. (C–E) SBT1, Xgadd45g and XETOR, respectively, are also restricted to progenitors and early differentiating neurons within the central CMZ
(bracket). (F) elrC is expressed in differentiating neurons in the most central CMZ region (arrow in panel F) and persists in post-mitotic cells of the RGC layer
and a subset of cells within the INL. (G) Xebf3 expression is also present in differentiating neurons of the central CMZ (arrow in panel G) and maintained in
mature RGCs.
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ification and possibly neuronal-specific exocytotic mecha-
nisms. Our results now provide compelling evidence that a
single ato-related bHLH factor may initiate differentiation
by directly activating components of diverse cellular
programs. Several transcriptional activators were identified
including Xebf2, Xebf3 and NKL. The Ebf genes and NKL
are sufficient and/or necessary for neurogenesis in several
model systems (Dubois et al., 1998; Garcia-Dominguez et
al., 2003; Lamar et al., 2001; Pozzoli et al., 2001),
confirming that targets for proneural bHLH factors are
critical components of a terminal differentiation program. Afew candidate target genes of the Ebf proteins have been
identified, including chromogranin A, olfactory-enriched G-
protein a-subunit and olfactory marker protein, but estab-
lishing a complete list of ebf and NKL transcriptional targets
will resolve the next tier within this cascade of differ-
entiation and clarify the specific contribution these genes
make to neurogenesis (Persson et al., 2004; Wang et al.,
2004).
In addition to transcriptional activation, repression of
select genes is likely to be critical during neurogenesis. For
example, genes encoding mitotic activators may have to be
repressed before neuronal precursors can properly exit the
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identified the transcriptional repressor XETOR as a com-
mon shared bHLH gene target. Overexpression of XETOR,
an X. laevis homolog of the MTG family of repressors,
expands the neural plate but actually inhibits the expression
of neuronal differentiation markers (Cao et al., 2002).
However, this result is in contrast with the fact that in the
chick spinal cord MTG proteins are required for neuronal
differentiation and, strikingly, MTG is required for the
ectopic neurogenesis that results from misexpressing X-
Ngnr-1a (Koyano-Nakagawa and Kintner, 2005). This
discrepancy may reflect a concentration-dependent function
for XETOR or may be due to valid species differences.
Alternatively, although XETOR may be required for neuro-
nal differentiation in some systems, overexpression may trap
cells at an early stage of differentiation, preventing them
from fully executing a terminal differentiation program.
Future studies will undoubtedly reveal the protein partners
and gene targets for MTG family members, thereby
clarifying its contribution to neuronal differentiation across
species.
Differentiating cells can also adjust molecule expression
by posttranscriptional regulation. Therefore, it was not
surprising that we identified the RNA binding protein elrC
as a bHLH target. Several members of the Hu RNA binding
protein family are conserved components of neuronal
differentiation and function to antagonize mRNA degra-
dation by binding to 3V AU-rich elements within target
transcripts (Brennan and Steitz, 2001). Evidence from other
species supports our finding that elrC is a direct target of
multiple ato-related bHLH factors in Xenopus. In Droso-
phila, ato is required for elav expression in the developing
eye (Suzuki and Saigo, 2000). Overexpression of ato-
related ngn1 in zebrafish promotes ectopic elrC expression,
and promoter analysis has revealed that multiple E-boxes
within the zebrafish elrC promoter are required for proper
neuronal expression of a reporter transgene (Kim et al.,
1997; Park et al., 2000). Despite the fact that there are
several Hu family members expressed in the developing
nervous system, elrC may be distinctive in being a direct
bHLH target. Detailed analysis of elrB, elrC and elrD in the
X. laevis retina reveals that elrC is turned on before elrB and
elrD in early differentiating progenitors and only elrC
expression overlaps with BrdU-incorporating progenitors
within the CMZ (Amato et al., 2005). This observation is
important because it is consistent with elrC being a direct
bHLH target within the retina, and it also emphasizes the
importance of posttranscriptional regulation in the early
steps of neurogenesis, suggesting that elrC makes a critical
early contribution to mRNA transcript regulation during the
initial steps of differentiation.
Critical cell cycle modification events accompany differ-
entiation (Ohnuma and Harris, 2003), and some cell cycle
regulator genes have been identified as candidate down-
stream targets of proneural bHLH factors (Hu et al., 2004;
Souopgui et al., 2002). For example, X. laevis p21-activatedkinase 3 (XPak3) has been shown to function downstream
of X-Ngnr-1 during primary neurogenesis to promote cell
cycle withdrawal of committed cells (Souopgui et al., 2002).
We identified the cell cycle regulator Xgadd45g as a shared
direct target of Xath5 and XNeuroD. Gadd45 genes appear
to be important negative regulators of growth control,
specifically promoting cell cycle arrest at the G2/M
transition (Mak and Kultz, 2004; Vairapandi et al., 2002;
Wang et al., 1999). Notably, in the Drosophila PNS, neural
precursors that are forced out of the G2/M arrest checkpoint
and into mitosis fail to differentiate properly, suggesting that
this cell cycle status may be linked to neural lineage
decisions. Our identification of the G2/M checkpoint gene
Xgadd45g as a proneural bHLH gene target implicates this
as a potentially conserved process. However, gadd45g is not
turned on exclusively by proneural bHLH factors as it is
also upregulated in mouse fibroblasts following activation
of the myogenic bHLH MyoD (Bergstrom et al., 2002).
Xgadd45g is expressed in dorsal mesoderm at early gastrula
stages (stage 10), which is consistent with regulation by
MyoD in vivo (de la Calle-Mustienes et al., 2002). This is
interesting because it suggests that gadd45g may represent a
downstream cell cycle regulator of both neurogenic and
myogenic bHLH factors. Because families of bHLH factors
regulate differentiation in a variety of tissue types, this
offers an intriguing strategy whereby all bHLH factors could
utilize an identical subprogram for cell cycle withdrawal, a
critical event associated with differentiation of all cell types.
Differentiating neurons undergo a number of morpho-
logical changes, including the formation of sometimes very
elaborate dendritic and axonal architectures. Even during
the early stages of these structural modifications, cells may
experience dramatic redistributions of cell volume and
intracellular components. Therefore, it is reasonable that
we identified SVOP as a direct target of Xath5 and
XNeuroD. SVOP has structural similarity to known synaptic
vesicle proteins and is enriched at synapses in the adult rat
brain (Janz et al., 1998). Although better recognized for
their function during vesicle release at mature synapses,
several components of exocytotic machinery are expressed
in early differentiating neurons, possibly contributing to
membrane insertion that accompanies migration and/or
axonal and dendritic outgrowth (Dabrowski et al., 2003;
Martinez-Arca et al., 2001). We observed that X. laevis
SVOP expression was more spatially and temporally
restricted than the other shared bHLH targets we identified
(to be reported elsewhere). Interestingly, the direct induction
of SVOP by Xath5 and XNeuroD was also relatively weak
in the animal cap assay, as compared to many other direct
targets we identified. This may reflect the fact that other co-
factors expressed in a restricted manner within the devel-
oping nervous system are required to cooperate with
proneural bHLH factors to maximally activate SVOP
expression. This would be analogous to observed temporal
differences in MyoD target gene activation. MyoD directly
activates early targets that include metabolic, cell cycle and
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functions synergistically with p38 kinase to directly
upregulate muscle-specific cytoskeletal genes (Bergstrom
et al., 2002).
We have not generated an exhaustive list of common
bHLH targets. Our profiling screen did not detect XBrn3d, a
known shared target of Xath5 and XNeuroD (Hutcheson
and Vetter, 2001). Nor did we identify components of lateral
inhibition signaling, including the known bHLH target X-
Delta-1. However, we have identified a number of critical
genes that are directly targeted by multiple ato-related
bHLH factors, suggesting that these genes may be important
for regulating neuronal differentiation of many neuronal
subtypes.
Specificity of proneural bHLH target activation
Although multiple proneural bHLH factors function
similarly by promoting neuronal differentiation, they also
demonstrate distinct functions in the generation of unique
neuronal subtypes. For example, within the mouse periph-
eral nervous system, Mash1 and ngns specify the formation
of autonomic and sensory neurons, respectively (Lo et al.,
2002). This instructive function may be attributed to
different bHLH factors targeting unique genes expressed
only in select neuronal lineages. Recent studies in Droso-
phila have revealed that nucleotide variability within and
flanking the core 6-bp E-box site to which proneural bHLH
factors bind can confer responsiveness to Atonal versus
scute factors (Powell et al., 2004). Vertebrate homologs of
ato and scute can activate distinct transcriptional programs
(Talikka et al., 2002), but it is not clear if distinguishing
features between ato family and as-c family E-box
sequences exist in vertebrates or whether this is due to
differential interactions with other co-factors. Our observa-
tion that Xath5EnR effectively blocks activity of ato-related
factors, but not that of Xash3, indicates that there may be
some differences in the promoter elements that are bound by
X. laevis ato and as-c family bHLH factors, either due to
differences in DNA-binding site recognition or interactions
with distinct trans-factors. Specificity of gene activation
may also occur within each bHLH subfamily. In the retina,
overexpression of the ato-related factors Xath5, XNeuroD
and Xath3 all generate a different repertoire of neuronal
subtypes (Kanekar et al., 1997; Perron et al., 1999b),
suggesting that each factor may activate unique subtype-
specific genes in addition to promoting terminal differ-
entiation. This idea is consistent with the fact that we
observed some differences in the PCR band patterns while
comparing the Xath5-hGR activated lanes alone to the
XNeuroD-hGR activated lanes in our FDD results (data not
shown). This suggests that Xath5 and XNeuroD may
function differentially within animal cap cells and activate
unique genes, although this remains to be confirmed.
Other factors likely contribute to the regulation of the
genes we identified as targets for Xath5 and XNeuroD.These genes do not all display pan-neural expression patterns
and, therefore, may be either actively repressed by other
factors in some differentiating neurons or may require a
critical co-factor for proneural bHLH activation. In addition,
expression of some genes is maintained in post-mitotic
neurons, such as mature retinal ganglion cells (Figs. 5F, G),
suggesting that, although bHLH factors such as Xath5may be
responsible for initial activation, some other factors must
sustain expression following bHLH downregulation.Acknowledgments
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